<p> although the majority, but there are still many patients find no reason,woolrich roma, and the rising incidence of lung cancer,giuseppe zanotti sneakers, as well as younger and younger.Yang Jin Kee still remember the day three years ago, Corey admitted a 17-year-old female students in advanced lung cancer. This girls just admitted to Sichuan University, detection of gene mutation is not found, treatment costs would more than ten thousand yuan a month. Girls were disappointed, puzzled, while their parents go out to buy things, upstairs and jumped down. Yang Jin remember always remember her,hollister paris, this is the first patients he worked 13 years at Corrie encountered jumping. "If she could stay down, technological advancements, might be able to find her target."Wyler House on the 8th floor,parajumpers france, there is the country's largest cancer center clinical trials of drugs, a lot of ongoing clinical trials of new drugs. Clinical trials of new drugs. Many people stereotype is the "mouse." In fact, clinical trials of drugs mainly refers to one,imitation louboutin pas cher, two and Phase III clinical trials of drugs,nobis femme, low test the efficiency of the drug in the past, the high toxicity of the drug is now accurate treatment just turn, high effectiveness,chaussure tn pas cher, very low toxicity. And it is based on genetic changes to the design of drugs, experimental grasp relatively large,barbour soldes, benefit more patients. At the same time, patients participate in clinical trials are not the rule of law the standard approach, the test is to give them a chance of survival.Some patients encountered EVIDENCE, first sentence and asked: "Is there new research I want to participate?." They are old lung cancer patient,giuseppe zanotti femme, after 7-8 years of follow-up,cheap toms, found that the benefits of drug trials,nobis homme, hope to have new drugs to help They survive.Currently a hot research in oncology is whether warning.Family genetic characteristics of lung cancer in the number of cancer is not clear. Some hereditary tumor is high,chaussure femme pas cher, such as nasopharyngeal cancer, breast cancer. Such as Hollywood actress Angelina Jolie breast cancer due to carry on the 1st gene.</p>
<p> received prophylactic bilateral mastectomy surgery to reduce the risk with cancer,doudoune parajumpers, it caused great concern.EVIDENCE team found that about 5 percent of lung cancer genetically, but lung cancer is a very large species, the patient very much, so they asked all these years, all the family,tn air max 2014 pas cher, there are more than 2-3 lung cancer patients,hollister outlet, should be recorded and tracked .The work carried out for six years in the country to track more than 500 cancer families, each family needs to collect blood samples of 7-8 individuals, of which about seven families who get lung cancer up to three or more. Hebei has a family member was found in a healthy genetic testing belonging to risk groups, EVIDENCE team to observe him, he really had lung cancer two years later.</p>
<p> it seems obvious growing, but the drug can not stop, a stop will seriously deteriorate. "It was with the point of view is not the same clinical community. People say do not eat no effect to medication, and we told them this drug stops, it will grow very slowly turned from very fast, we must continue to use single this measure , you can put the median survival of patients extended for six months or so. ""The study of tumors is endless, because too complex, it will evolve." Zhang Xu Chao said.Cancer is a very tricky opponent, targeted drugs from second-generation to third generation now, the cancer drug offensive and defensive back and forth.EVIDENCE team with MIT, Harvard and other forces, working with the other driver gene in lung cancer fight --c-MET. They found that the gene "has suddenly magnify the role of" EVIDENCE is the leader of this global study, he is expected to announce the final results after two years. The preliminary data encouraging: in primary mutations, c-MET mutations account for 5% -10%. While the resistant patients,nike shox, this gene also play a role in fighting drugs. EGFR mutations in patients with 5% -20% of the drug because of c-MET gene amplification.Experimental and genetic studies of new drugsSome patients encountered EVIDENCE,abercrombie, first sentence and asked: "Is there new research I want to participate?." They are old lung cancer patient, after 7-8 years of follow-up, found that the benefits of drug trials,louboutin femme pas cher, hope to have new drugs to help They survive.Patients can detect mutations.</p>
相关的主题文章：
- http://www.maples-syrup.com/marrons_cafe/clever.cgi?mode=res&no=4574
- http://kujiraduki.fakefur.jp/p-nikki/apeboard_plus.cgi/apeboardp_mt.cgi/
- http://hhiis.cn/home.php?mod=space&uid=0
- http://jieda518.cn/news/html/?24581.html
- http://ejnqbbs.com/bbs/forum.php?mod=viewthread&tid=567367
- http://nastudios.cn/bbs/forum.php?mod=viewthread&tid=14859
- http://sjh.bbs.windplay.cn/forum-53-1.html?mod=spacecp&ac=blog&blogid=
- http://lishuishitan.com/bbs/forum.php?mod=viewthread&tid=14810